Down with the news, page-9

Well I must admit that the low sp has got me a bit baffled, but that's the stock market for you.

Within the last two years the sp spent much time between 6c and 8c.

Then there were many risks. Lack of funds, clinical trial to run, would enrollments come, would it run behind schedule like clinical trials always do, would there be many drop outs, would there be safety or pain issues etc.

Now full enrollment is due any day, we have had hardly any drop outs, we have had promising snippets of data and the funding is good.

ok, there has been a wee bit of dilution, but even with that I would value ftt twice what it was - but yet it is far lower.

I guess we need to be a bit more patient.

To be honest I now always look to hold for more than 12 months for reduced cap gains anyway, so I shouldn't really be bothered about the sp now.

cheers